about
Mechanisms of transcriptional repression of cell-cycle G2/M promoters by p63.Palatogenesis and cutaneous repair: A two-headed coinTooth agenesis and orofacial clefting: genetic brothers in arms?A role for chromosomal protein HMGN1 in corneal maturationAltered mRNA Splicing, Chondrocyte Gene Expression and Abnormal Skeletal Development due to SF3B4 Mutations in Rodriguez Acrofacial DysostosisImpaired repair of cyclobutane pyrimidine dimers in human keratinocytes deficient in p53 and p63TAp63 is a transcriptional target of NF-kappaB.Genetic disorders of the skeleton: a developmental approachp63 expression in adamantinoma.Morpho-regulation of ectodermal organs: integument pathology and phenotypic variations in K14-Noggin engineered mice through modulation of bone morphogenic protein pathway.Pathway Regulation of p63, a Director of Epithelial Cell FateAdditive effect of TAp63 deficiency on the adrenocortical dysplasia (acd) phenotype.Role of p63 in Development, Tumorigenesis and Cancer ProgressionAssociation of generalized aggressive periodontitis and ectrodactyly-ectodermal dysplasia-cleft syndrome.Management of a Giant Omphalocele with Non-Cross-Linked Intact Porcine-Derived Acellular Dermal Matrix (Strattice) Combined with Vacuum Therapy.Are interactions with p63 and p73 involved in mutant p53 gain of oncogenic function?P63 regulates tubular formation via epithelial-to-mesenchymal transitionThe proline-rich domain in p63 is necessary for the transcriptional and apoptosis-inducing activities of TAp63Current concepts in genetics of nonsyndromic cleftsNegative feedback between TAp63 and Mir-133b mediates colorectal cancer suppression.A symphony of regulations centered on p63 to control development of ectoderm-derived structures.Unlocking Mendelian disease using exome sequencing.Mapping genetic alterations causing chemoresistance in cancer: identifying the roads by tracking the drivers.FGF8, c-Abl and p300 participate in a pathway that controls stability and function of the ΔNp63α protein.New p63 targets in keratinocytes identified by a genome-wide approach.A dominant mutation etiologic for human tricho-dento-osseous syndrome impairs the ability of DLX3 to downregulate ΔNp63α.Genome-wide characterization reveals complex interplay between TP53 and TP63 in response to genotoxic stress.Inhibition of CD95-mediated apoptosis through beta 1 integrin in the HSG epithelial cell line.p63 drives invasion in keratinocytes expressing HPV16 E6/E7 genes through regulation of Src-FAK signalling.p63 expression in salivary gland tumors: role of DeltaNp73L in neoplastic transformation.A rare association of B cell lymphoma and ectodermal dysplasia presenting with protein-losing enteropathy.Identification of vitamin D receptor as a target of p63.Tumor suppressor proteins are differentially affected in human ependymoblastoma and medulloblastoma cells exposed to nerve growth factor.2008 International Conference on Ectodermal Dysplasias Classification: conference report.The Changing Landscape in the Genetic Etiology of Human Tooth Agenesis.Comprehensive genetic analysis of OEIS complex reveals no evidence for a recurrent microdeletion or duplication.Giant cell tumor of bone express p63.ΔNp63α Suppresses TGFB2 Expression and RHOA Activity to Drive Cell Proliferation in Squamous Cell Carcinomas
P2860
Q25256716-D3946827-B0DC-41C0-B2F0-9B8C7EAAFC08Q26823939-F59D2C38-B8B5-4132-8A1A-8259D1C5E384Q28076789-0D7C4F80-9930-4FFE-816E-19012BD362A0Q28585789-7133DC68-6EB5-46B7-8FD0-D9155ED95888Q28595827-89272083-6689-410A-9099-D4A6971EA3E3Q33772427-6411A51A-B8FA-46FB-8108-4DA59E04A615Q33866001-1DE3A5D8-DCB1-4A36-97CC-674B249C3F50Q33906292-2DC63226-521F-4923-97C8-50935CCDC771Q33933144-8514ACB7-91A9-4CE6-8BC4-788CB4F86771Q35096113-FFC495D6-5CB6-4B42-A6D0-18B0C283DE56Q35545782-7AB0D078-BF90-4C10-AF0E-FB0A8D3FF1B6Q35819408-5AE18A2E-D628-4199-B79A-A01014BA9AF8Q36284945-F66D01AB-07D1-43DB-87B4-10FE5E8F8021Q36377830-966B7E4D-3077-4AD5-B398-B4910D795423Q36459971-62534EF0-3FCF-4447-91A6-98C29F32A1BDQ36777361-9CD4D957-54A2-4270-BE5C-129078B2405CQ36998524-BA377D1D-D6BA-4DF5-BEF3-0B12640552DAQ37142886-F28DAEAC-393A-462C-AC2F-ACCE4882DA0FQ37409808-E1D5BF97-29CC-4977-A48C-D381EB8C0C31Q37699390-D69689F4-E45E-4448-89BB-5752206BBC50Q37895920-9DB910FD-CA77-4742-9CDF-3A3A9389D618Q37932636-2F713A5D-E4E9-4064-BE94-F270AE5F80A4Q38087850-589C8941-D17C-44FF-A83E-E8C07AC9C8B6Q38882470-11573ABE-7AD4-4283-A2A6-655D57263E63Q38977591-34D5BB52-66CF-40C1-9A3D-ABCC2FD1C9B7Q39552907-47BFF23B-C2DB-414E-86FD-DDBDB6CFCB6FQ40165187-A3F4AD90-EAC1-468A-B797-62755D6CD963Q40242440-02B42FB4-7A4A-414D-9E07-56266AEAA6D4Q40911127-275D1C4C-A0C1-47D9-ACE8-ADE911F3F1D8Q42486223-36E7FCCB-4931-453E-96B2-5629FC2D5C60Q42582134-757B5977-BDE9-4427-92A0-877863911A6DQ46931406-11D136B7-F594-40A8-897A-43E2D3D79F86Q48191239-FDD90891-4BFB-4FC7-9603-E53A9835970AQ53189138-B9059ACF-4EDA-4E76-931A-9F80AE745B32Q53958309-64FE4B71-1E33-454A-AC4E-BCAAED280033Q54394330-DA8F9A4E-CC75-4059-B615-6C9DDCDCF67BQ54544116-C7E95D46-579D-46E4-B724-1F49C1CA3DD4Q58721269-0001B758-3D15-4C3B-BFD3-5EEEB6CA3038
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
name
P63 gene mutations and human developmental syndromes.
@ast
P63 gene mutations and human developmental syndromes.
@en
P63 gene mutations and human developmental syndromes.
@nl
type
label
P63 gene mutations and human developmental syndromes.
@ast
P63 gene mutations and human developmental syndromes.
@en
P63 gene mutations and human developmental syndromes.
@nl
prefLabel
P63 gene mutations and human developmental syndromes.
@ast
P63 gene mutations and human developmental syndromes.
@en
P63 gene mutations and human developmental syndromes.
@nl
P2093
P2860
P356
P1476
P63 gene mutations and human developmental syndromes.
@en
P2093
Ben C J Hamel
Han G Brunner
Hans van Bokhoven Hv
P2860
P304
P356
10.1002/AJMG.10778
P577
2002-10-01T00:00:00Z